158 related articles for article (PubMed ID: 34078315)
1. Promoting HIV indicator condition-guided testing in hospital settings (PROTEST 2.0): study protocol for a multicentre interventional study.
Bogers SJ; Schim van der Loeff MF; Davidovich U; Boyd A; van der Valk M; Brinkman K; de Bree GJ; Reiss P; van Bergen JEAM; Geerlings SE;
BMC Infect Dis; 2021 Jun; 21(1):519. PubMed ID: 34078315
[TBL] [Abstract][Full Text] [Related]
2. Improving indicator-condition guided testing for HIV in the hospital setting (PROTEST 2·0): A multicenter, interrupted time-series analysis.
Bogers SJ; Schim van der Loeff MF; Boyd A; Davidovich U; van der Valk M; Brinkman K; Sigaloff K; Branger J; Bokhizzou N; de Bree GJ; Reiss P; van Bergen JEAM; Geerlings SE;
Lancet Reg Health Eur; 2022 Dec; 23():100515. PubMed ID: 36246146
[TBL] [Abstract][Full Text] [Related]
3. Current evidence on the adoption of indicator condition guided testing for HIV in western countries: A systematic review and meta-analysis.
Bogers SJ; Hulstein SH; Schim van der Loeff MF; de Bree GJ; Reiss P; van Bergen JEAM; Geerlings SE;
EClinicalMedicine; 2021 May; 35():100877. PubMed ID: 34027336
[TBL] [Abstract][Full Text] [Related]
4. Tracking missed opportunities for an early HIV diagnosis in a population of people living with HIV with known time of infection.
Basoulis D; Kostaki EG; Paraskevis D; Hatzakis A; Psichogiou M
Sex Transm Infect; 2022 Mar; 98(2):79-84. PubMed ID: 33608478
[TBL] [Abstract][Full Text] [Related]
5. Opportunities for improved indicator-based HIV testing in the hospital setting: a structural equation model analysis.
Bogers S; Boyd A; Schim van der Loeff M; Geerlings S; Davidovich U;
AIDS Care; 2024 Jun; 36(6):840-848. PubMed ID: 37683267
[TBL] [Abstract][Full Text] [Related]
6. Comparison of two HIV testing strategies in primary care centres: indicator-condition-guided testing vs. testing of those with non-indicator conditions.
Menacho I; Sequeira E; Muns M; Barba O; Leal L; Clusa T; Fernandez E; Moreno L; Raben D; Lundgren J; Gatell JM; Garcia F; Cayuelas L; Aragunde V; Vergara M; Catalan M; Moreno MA; Hormigo G; Siso A; Herreras Z; Sebastian L; Benito L; Picas A; Hoyo J; Giner MJ; Cararach D; Moles E; Moro ML; Arrabal P; Roca D; Prego S; Ferrer X; Egido A; Ventosa C; Garcia S; Muñoz S; Massana A; Sole J; Curiel M; Heras F; Leon A
HIV Med; 2013 Oct; 14 Suppl 3():33-7. PubMed ID: 24033901
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Enhancing indicator condition-guided HIV testing in Taiwan: a nationwide case-control study from 2009 to 2015.
Lee CY; Lin YP; Lin CY; Lu PL; Liang FW
BMC Public Health; 2024 Apr; 24(1):967. PubMed ID: 38580963
[TBL] [Abstract][Full Text] [Related]
9. The need to scale up HIV indicator condition-guided testing for early case-finding: a case-control study in primary care.
Joore IK; Twisk DE; Vanrolleghem AM; de Ridder M; Geerlings SE; van Bergen JE; van den Broek IV
BMC Fam Pract; 2016 Nov; 17(1):161. PubMed ID: 27855639
[TBL] [Abstract][Full Text] [Related]
10. Improving the evidence for indicator condition guided HIV testing in Europe: Results from the HIDES II Study - 2012 - 2015.
Raben D; Sullivan AK; Mocroft A; Kutsyna G; Hadžiosmanović V; Vassilenko A; Chkhartisvili N; Mitsura V; Pedersen C; Anderson J; Begovac J; Bak Dragsted U; Bertisch B; Grzeszczuk A; Minton J; Necsoi VC; Kitchen M; Ajana F; Sokhan A; Comi L; Farazmand P; Pesut D; De Wit S; Gatell JM; Gazzard B; d'Arminio Monforte A; Rockstroh JK; Yazdanpanah Y; Champenois K; Jakobsen ML; Lundgren JD;
PLoS One; 2019; 14(8):e0220108. PubMed ID: 31408476
[TBL] [Abstract][Full Text] [Related]
11. General practitioners' barriers and facilitators towards new provider-initiated HIV testing strategies: a qualitative study.
Joore IK; van Roosmalen SL; van Bergen JE; van Dijk N
Int J STD AIDS; 2017 Apr; 28(5):459-466. PubMed ID: 27207253
[TBL] [Abstract][Full Text] [Related]
12. Indicator condition-guided HIV testing with an electronic prompt in primary healthcare: a before and after evaluation of an intervention.
Cayuelas Redondo L; Ruíz M; Kostov B; Sequeira E; Noguera P; Herrero MA; Menacho I; Barba O; Clusa T; Rifa B; González de la Fuente EM; González Redondo E; García F; Sisó Almirall A; León A
Sex Transm Infect; 2019 Jun; 95(4):238-243. PubMed ID: 30679391
[TBL] [Abstract][Full Text] [Related]
13. The importance of registration of sexual orientation and recognition of indicator conditions for an adequate HIV risk-assessment.
Joore IK; Geerlings SE; Brinkman K; van Bergen JE; Prins JM
BMC Infect Dis; 2017 Feb; 17(1):178. PubMed ID: 28241753
[TBL] [Abstract][Full Text] [Related]
14. Assessment of HIV testing recommendations in Greek specialty guidelines: A missed opportunity and room for improvement for recommending testing.
Akinosoglou K; Kostaki EG; Paraskevis D; Gogos CA
AIDS Care; 2021 Oct; 33(10):1312-1315. PubMed ID: 33678071
[TBL] [Abstract][Full Text] [Related]
15. Auditing HIV Testing Rates across Europe: Results from the HIDES 2 Study.
Raben D; Mocroft A; Rayment M; Mitsura VM; Hadziosmanovic V; Sthoeger ZM; Palfreeman A; Morris S; Kutsyna G; Vassilenko A; Minton J; Necsoi C; Estrada VP; Grzeszczuk A; Johansson VS; Begovac J; Ong EL; Cabié A; Ajana F; Celesia BM; Maltez F; Kitchen M; Comi L; Dragsted UB; Clumeck N; Gatell J; Gazzard B; d'Arminio Monforte A; Rockstroh J; Yazdanpanah Y; Champenois K; Jakobsen ML; Sullivan A; Lundgren JD;
PLoS One; 2015; 10(11):e0140845. PubMed ID: 26560105
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of HIV testing recommendations in specialty guidelines for the management of HIV indicator conditions.
Lord E; Stockdale AJ; Malek R; Rae C; Sperle I; Raben D; Freedman A; Churchill D; Lundgren J; Sullivan AK;
HIV Med; 2017 Apr; 18(4):300-304. PubMed ID: 27535357
[TBL] [Abstract][Full Text] [Related]
17. Missed opportunities for HIV testing of patients diagnosed with an indicator condition in primary care in Catalonia, Spain.
Agustí C; Montoliu A; Mascort J; Carrillo R; Almeda J; Elorza JM; Aragón M; Casabona J
Sex Transm Infect; 2016 Aug; 92(5):387-92. PubMed ID: 26888659
[TBL] [Abstract][Full Text] [Related]
18. Missed opportunities for HIV testing persist despite a single educational intervention: how can we close this evidence-practice gap?
King K; Seah J; Cheng A; Whiting S; Hoy J
Intern Med J; 2020 Mar; 50(3):285-292. PubMed ID: 31276275
[TBL] [Abstract][Full Text] [Related]
19. Overlooked cases of HIV infection: An Italian tale of missed diagnostic opportunities.
van den Bogaart L; Ranzani A; Oreni L; Giacomelli A; Corbellino M; Rusconi S; Galli M; Antinori S; Ridolfo AL
Eur J Intern Med; 2020 Mar; 73():30-35. PubMed ID: 31635999
[TBL] [Abstract][Full Text] [Related]
20. HIV testing in patients presenting with indicator conditions in outpatient settings: offer and uptake rates, and educational and active interventions.
Youssef E; Sanghera T; Bexley A; Hayes M; Perry N; Dosekun O; Perera S
Int J STD AIDS; 2018 Nov; 29(13):1289-1294. PubMed ID: 29979144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
